CompletedNot Applicable

Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment

France28 participantsStarted 2024-10-01

Plain-language summary

Moncentric pilot study conducted in the addictology department of the Pau Hospital, designed to demonstrate the benefit of protein supplementation on craving in patients with a substance use disorder at the start of their treatment for addiction. This study will be conducted according a crossover design with a one-week phase with protein supplementation (P) and a one-week phase without protein supplementation (SP).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female * Aged 18 and over * Admitted for complex care in the addictology department * Person affiliated to or benefiting from a social security scheme * Free, informed and written consent signed by the participant and the investigator Exclusion Criteria: * Allergy to milk protein * Admitted to hospital for less than 3 weeks * Severe somatic or psychiatric pathology incompatible with understanding assessment tools * Difficulty understanding and/or writing French * Presumed non-compliant in completing the patient diary * Person participating in another research study with an exclusion period still in progress * Person under legal protection (guardianship, curatorship)

What they're measuring

Evolution of craving for the main substance

Timeframe: This outcome will be assessed twice a day (morning and afternoon) from day 8 to day 21, during the period with and without protein supplementation.

Trial details

NCT IDNCT06459609

SponsorCentre Hospitalier de PAU

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-24

View on ClinicalTrials.gov More Addiction trials